Neurovascular Devices/Interventional Neurology Market is Anticipated to Grow at a CAGR of 8.10% and is also Expected to Reach USD 3.98 Billion by 2026, Asserts DelveInsight

News provided by

Nov 24, 2021, 11:30 ET

As per DelveInsight Analysis for Neurovascular Devices market, the increasing prevalence of neurological conditions, rising demands for minimally-invasive procedures are some of the key factors, which are expected to increase the overall demand for Neurovascular Devices, thus driving the growth of the Neurovascular Devices market.

LAS VEGAS, Nov. 24, 2021 /PRNewswire/ -- DelveInsight's Neurovascular Devices Market Insights and Forecast report provides the current and forecast Neurovascular Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Neurovascular Devices Market.

Some of the salient features from the Neurovascular Devices Market report:

As per an analysis by DelveInsight, North America is expected to dominate the overall Neurovascular Devices Market during the forecast period.
Major pharma players working proactively in the Neurovascular Devices Market include Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp., and others.
DelveInsight estimates that the Global Neurovascular Devices/ Interventional Neurology Market was valued at USD 2.63 billion in 2020, growing at a CAGR of 8.10% during the forecast period from 2021 to 2026, to reach USD 3.98 billion.
On April 21, 2021, Medtronic had received the FDA approval for Pipeline Flex Embolization Device with Shield Technology.
On January 07, 2019, Terumo Corporation had announced that FDA had granted the Premarket Approval for the novel Intrasaccular Aneurysm Treatment Device for the treatment of intracranial wide-neck bifurcation aneurysms.

To pick on the latest highlights related to Neurovascular Devices Market, get the snapshot of the key highlights entailed in the Neurovascular Devices Market report.

Neurovascular Devices Overview

Neurovascular Devices/Interventional Neurology devices are devices that comprise coils, stents, clot-retrieving devices and other devices for the treatment of neurovascular disorders such as brain aneurysms and neurovascular thrombectomy. Clot retrieval devices, suction and aspiration devices are used in the removal of blood clots from the arteries and veins of the brain that can also lead to stroke. Neurovascular devices are used for the treatment of disorders that are associated with the blood vessels that carry oxygen-rich blood to the brain region.

Interested in knowing how the Neurovascular Devices Market will be growing by 2026? Click to get a snapshot of Neurovascular Devices Market Analysis

Neurovascular Devices Market Insight

Geographically, the global Neurovascular Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination in North America is observed majorly due to the growing cases of neurological disorders in the United States that require treatment through Neurovascular Devices.

Owing to the growing patient population suffering from chronic neurological disorders and the launch and approval of embolization devices in various countries, there is an anticipated growth boost for the Neurovascular Devices market. For instance, on April 14, 2020, Keystone Heart Ltd. had announced that their cerebral embolic protection device, named TRIGUARD 3 had been granted the CE Mark approval. Also, on October 21, 2019, Shape Memory Medical had announced that they had received CE Mark approval for the Trellix embolic coil system.

On May 07, 2019, Rapid Medical had announced the Food and Drug Administration approval of the novel Temporary Aneurysm Embolization Assist Device, Comaneci, a new category of temporary coil embolization assists devices.

Learn more about the Neurovascular Devices Market Landscape @ Neurovascular Devices Market Landscape

Neurovascular Devices Market Drivers and Barriers

An increase in the prevalence rate of brain aneurysms suffering population, market development related to products and expansions, and the launch as well as approval of new innovative devices will lead to an increased demand for embolization devices, further leading to an increase in the Neurovascular Devices market growth. Apart from that rising incidence of hypertension across the globe leading to brain aneurysms may also lead to significant growth of the Neurovascular Devices market.

The demand for Neurovascular Devices is primarily affected by the outbreak of the COVID-19 pandemic because of the delay in elective surgeries. Undiagnosed and unreported brain aneurysm cases also act as setbacks for the Neurovascular Devices market.

To get a deeper understanding of the driving factors related to the Neurovascular Devices Market, get a snapshot of the Neurovascular Devices Market Dynamics

Scope of the Neurovascular Devices Market Report

Study Period: 2018-2026

Key Companies: Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp.

Neurovascular Devices Market Segmentation

By Product Type

Cerebral Embolization and Aneurysm Coiling devices

Embolic Coils
Flow Diversion Devices
Liquid Embolic Agents

Cerebral Balloon Angioplasty and Stenting System

Embolic Protection Systems
Carotid Artery Stents

Neurothrombectomy Devices

Clot Retrievers
Suction devices
Vascular Snare

Support Devices

Micro Catheters
Micro Guidewires

By Application

Stroke
Cerebral Aneurysm
Carotid artery Stents
Other Diseases

By End-User

Hospitals
Ambulatory Surgical Centers

By Geography

North America
Europe
Asia-Pacific
Rest of World

Delveinsight Analysis: Global Neurovascular Devices/Interventional Neurology Market was valued at USD 2.63 billion in 2020, growing at a CAGR of 8.10% during the forecast period from 2021 to 2026, to reach USD 3.98 billion.

Table of Contents

1	Neurovascular Devices/Interventional Neurology Market Report Introduction
2	Neurovascular Devices/Interventional Neurology Market Executive summary
3	Regulatory and Patent Analysis
4	Neurovascular Devices/Interventional Neurology Market Key factors analysis
5	Neurovascular Devices Porter's Five Forces Analysis
6	COVID-19 Impact Analysis on Neurovascular Devices Market
7	Neurovascular Devices Market Layout
8	Neurovascular Devices Global Company Share Analysis – Key 3-5 Companies
9	Neurovascular Devices/Interventional Neurology Market Company and Product Profiles
	9.1 Johnson & Johnson 9.2 Medtronic 9.3 Stryker 9.4 Terumo Corporation 9.5 Penumbra, Inc. 9.6 Microport Scientific Corporation 9.7 Kaneka Corporation 9.8 Integer Holdings Corporation 9.9 phenox GmbH 9.10 Perflow Medical Ltd. 9.11 Balt 9.12 Rapid Medical 9.13 ASAHI INTECC CO., LTD. 9.14 Acandis GmbH 9.15 Cerus Endovascular Inc.
10	Project Approach
11	KOL Views
12	DelveInsight Capabilities
13	Disclaimer
14	About DelveInsight

Learn more about the report offerings @ Neurovascular Devices Market Outlook

Understand the Competition, Risk Assessment and effective Research and Development approach to take value-based decisions.

"Choroidal Neovascularization Pipeline Insights, 2021" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Choroidal Neovascularization market. A detailed picture of the Choroidal Neovascularization pipeline landscape is provided, which includes the disease overview, treatment guidelines, and key companies involved such as Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp, and others.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market was valued at USD 681.36 million in 2020, growing at a CAGR of 6.11% during the forecast period from 2021 to 2026 to reach USD 969.17 million by 2026. The report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends, market drivers, market barriers and key companies involved such as Stryker, Penumbra, Vesalio, Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, and many others.

Neurovascular Coiling Assist Devices Market

DelveInsight's 'Neurovascular Coiling Assist Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth understanding of Neurovascular Coiling Assist Devices and the historical and forecasted Neurovascular Coiling Assist Devices market trends, market drivers, market barriers and key companies involved such as Acandis GmBH, BALT Extrusion, Johnson & Johnson (Cerenovus), Medtronic Plc, Stryker, Terumo (MicroVention), and others.

Peripheral Vascular Clot Management Interventions Market

DelveInsight's 'Peripheral Vascular Clot Management Interventions Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of peripheral vascular clot management interventions and the historical and forecasted peripheral vascular clot management interventions market trends, market drivers, market barriers and key companies involved such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, Argon Medical Devices, Inc., Control Medical Technology, B. Braun Melsungen AG., Inari Medical, and others.

Nerve Monitoring Systems Market

Global Nerve Monitoring Systems Market was valued at USD 1.23 billion in 2020, growing at a CAGR of 4.17% during the forecast period from 2021 to 2026, to reach USD 1.72 billion by 2026. The report delivers an in-depth understanding of Nerve Monitoring Systems and the historical and forecasted Nerve Monitoring Systems market trends, market drivers, market barriers and key companies involved such as Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Innopsys Inc, Neurovision Medical Products, NeuroWave Systems Inc, Cadwell Industries, Dr. Langer Medical GmbH, Inomed Medizintechnik GmbH, Symmetry Surgical, Checkpoint Surgical Inc, and many others.

Vascular Access Devices Market

Global Vascular Access Devices Market was valued at USD 4.31 billion in 2020, growing at a CAGR of 6.64% during the forecast period from 2021 to 2026, to reach USD 6.13 billion by 2026. The report delivers an in-depth understanding of Vascular Access Devices and the historical and forecasted Vascular Access Devices market trends, market drivers, market barriers and key companies involved such as Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Smiths Group PLC, Nipro Medical Corporation, and many others.

Neurovascular Catheters Devices Market

DelveInsight's 'Neurovascular Catheters Devices - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Neurovascular Catheters Devices and the historical and forecasted Neurovascular Catheters Devices market trends. Neurovascular Catheters Devices market will be covered in-depth in the report comprising of company overview, financial overview, product overview and company share analysis of key players.

Browse Through Our Blog Posts